<DOC>
	<DOC>NCT00569504</DOC>
	<brief_summary>The purpose of this study is to assess the cross-sectional prevalence of the metabolic syndrome in patients with schizophrenia taking antipsychotics.</brief_summary>
	<brief_title>Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics</brief_title>
	<detailed_description>Schizophrenic patients taking any kind of antipsychotics for at least 1 year at the Seoul National Hospital will be participated in this study. we are planning to enroll approximately 1000 patients with schizophrenia. For each subject - abdominal circumference - body mass index - lipid profile : TG, HDL-chlo, total chol - systolic/diastolic blood pressure - fasting blood glucose will be measured. we will calculate the rates of patients who meet the criteria for the Metabolic syndrome. 1. Abdominal obesity : absolute criteria 2. 2 or more of followings 1. Triglyceride ≥ 150mg/dL or ongoing treatment 2. HDL-cholesterol ＜ 40mg/dL (men) HDL-cholesterol ＜ 50mg/dL (female) or ongoing treatment 3. Hypertension 130mmHg ≥ systolic 85mmHg ≥ diastolic or ongoing treatment 4. FBS ≥ 100mg/dL or previous diagnosis of type II DM</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Patients taking a same antipsychotics at least more than one year schizophrenia or schizoaffective disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>antipsychotics</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>prevalence</keyword>
</DOC>